oral DTaP vaccine (VaxForm)

VaxForm's oral DTaP vaccine is a preclinical subunit vaccine candidate designed for the prevention of diphtheria, tetanus, and pertussis (whooping cough). Unlike traditional DTaP vaccines that are administered via intramuscular injection, this formulation is designed for oral administration. The vaccine presents diphtheria toxoid, tetanus toxoid, and pertussis antigens to the immune system through the oral route to induce protective systemic and mucosal immunity. This approach aims to improve patient compliance and ease of administration, particularly in resource-limited settings, by eliminating the need for needles and specialized medical personnel for administration.

Other names

oral diphtheria-tetanus-acellular pertussis vaccineVaxForm oral DTaP vaccinediphtheria + tetanus + acellular pertussis vaccine